Pharmacovigilance Summary Report: October 1st to December 31st 2024 (Q2)
- Version
- Download 21
- File Size 821.79 KB
- File Count 1
- Create Date February 11, 2025
- Last Updated February 18, 2025
Pharmacovigilance Summary Report: October 1st to December 31st 2024 (Q2)
In Quarter 2 (from October 1 to December 31, 2024), the National Pharmacovigilance Centre received 278 reports of suspected adverse drug reactions (SADRs). Among these, 271 reports (97.48%) were initial reports and 7 reports (2.52%) were follow-up reports. To avoid duplication, only one copy of each Individual Case Safety Report (ICSR) was included in the analysis, resulting in a total of 271 reports for this quarterly summary. All 271 initial reports pertained to suspected adverse drug reactions (SADRs).
Attached Files
| File | Action |
|---|---|
| PV Quarterly Summary Quarter 2 (2024_2025).pdf | Download |
